dextrothyroxine has been researched along with diethylcarbamazine in 202 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (11.39) | 18.7374 |
| 1990's | 56 (27.72) | 18.2507 |
| 2000's | 48 (23.76) | 29.6817 |
| 2010's | 37 (18.32) | 24.3611 |
| 2020's | 38 (18.81) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XR; Cheng, SZ; Cheng, WF; Gan, GB; Luo, LF; Piessens, WF; Tao, ZH; Wang, SH; Ye, YM; Zheng, HJ | 2 |
| Cartel, JL; Martin, PM; Moulia-Pelat, JP; Nguyen, LN; Roux, JF; Spiegel, A | 1 |
| Kurniawan, A; Partono, F; Rukmono, B; Sartono, E; Setiowati, WE; Supali, T; Wibowo, H | 1 |
| Cartel, JL; Martin, PM; Moulia-Pelat, JP; Nguyen, L; Roux, JF; Spiegel, A | 1 |
| Cardines, R; Cartel, JL; Martin, PM; Moulia-Pelat, JP; Nguyen Ngnoc, L; Plichart, R; Roux, JF; Spiegel, A | 1 |
| Bryan, RT; Eberhard, ML; Hightower, AW; Lammie, PJ; McNeeley, DF; McNeeley, MB; Richards, FO; Spencer, HC | 1 |
| Eberhard, ML; Lammie, PJ; Roberts, JM; Wamae, CN | 1 |
| Cardines, R; Cartel, JL; Martin, PM; Nguyen Ngnoc, L; Plichart, R; Roux, JF; Spiegel, A | 1 |
| Barbazan, P; Cartel, JL; Martin, PM; Nguyen, L; Roux, JF; Sechan, Y; Spiegel, A | 1 |
| Danis, M; Datry, A; Durepaire, R; Felix, H; Gaxotte, P; Gentilini, M; Paris, L | 1 |
| Chen, XR; Cheng, SH; Cheng, WF; Gan, GB; Luo, LF; Piessens, WF; Tao, ZH; Wang, SH; Ye, YM; Zheng, HJ | 2 |
| Eberhard, ML; Lammie, PJ; Richards, FO; Weil, GJ | 1 |
| Cartel, JL; Martin, PM; Nguyen, L; Plichart, R; Roux, JF; Spiegel, A | 1 |
| Baird, JK; Masbar, S; Riberu, W | 1 |
| Bernard, Y; Bryan, RT; Eberhard, ML; Hightower, AW; Lammie, PJ; McNeeley, DF; McNeeley, MB; Richards, FO; Spencer, HC | 1 |
| Cartel, JL; Genelle, B; Nguyen, L; Roux, JF; Spiegel, A | 1 |
| Chatterjee, RK; Misra, S; Singh, DP | 1 |
| Frederick, S; Kumaraswami, V; Ottesen, EA; Perumal Pillai, SV; Prabhakar, R; Sadanandam, A; Tripathy, SP; Vijayasekaran, V | 1 |
| Liu, LX; Weller, PF | 1 |
| Awadzi, K; Breckenridge, A; Edwards, G; Orme, M | 1 |
| Noireau, F | 1 |
| Donnelly, JJ; Haldar, JP; Khatami, M; Lok, JB; Rockey, JH | 1 |
| Thylefors, B | 1 |
| Basset, A; Basset, D; Bouree, P; Lariviere, M | 1 |
| Howard, G; Litchfield, TM; Mackenzie, CD; Nwachukwu, MA | 1 |
| Aziz, M; Basset, D; Beauvais, B; Derouin, F; Gaxotte, P; Ginoux, J; Lariviere, M; Schulz-Key, H; Vingtain, P; Weimann, D | 1 |
| Awadzi, K; Breckenridge, AM; Edwards, G; Orme, M | 1 |
| Albiez, EJ; Büttner, DW; Greene, BM; Kaiser, A; Newland, HS; Taylor, HR; White, AT | 1 |
| Aziz, MA; Badiane, S; Diallo, JS; Diallo, S; Diop-Mar, I; Gaxotte, P; Lariviere, M; N'Dir, O; Py, D; Schulz-Key, H | 1 |
| Donnelly, JJ; Haldar, JP; Hill, DE; Khatami, M; Lok, JB; Rockey, JH; Xi, MS | 1 |
| Breckenridge, A; Edwards, G; Orme, M | 1 |
| Toufic, N | 1 |
| Bianco, AE; Doenhoff, MJ; Muller, RL; Nwachukwu, MA; Townson, S | 1 |
| Aziz, MA; Cupp, EW; D'Anna, SA; Greene, BM; Keyvan-Larijani, E; Murphy, RP; Newland, HS; Taylor, HR; White, AT | 1 |
| Badiane, S; Diallo, JS; Diallo, S; Diop Mar, I; Ndir, O | 1 |
| Awadzi, K; Aziz, MA; Dadzie, KY; Fulford, AJ; Gilles, HM; Schulz-Key, H | 1 |
| Awadzi, K; Aziz, MA; Bird, AC; Dadzie, KY; Gilles, HM; Schulz-Key, H | 1 |
| Aziz, MA; Cupp, EW; D'Anna, SA; Goldschmidt, LP; Greene, BM; Murphy, RP; Newland, HS; Schulz-Key, H; Taylor, HR; White, AT | 1 |
| Keyvan-Larijani, E; Newland, HS; Taylor, HR | 1 |
| Marriner, S | 1 |
| Awadzi, K; Aziz, MA; Dadzie, KY; Gilles, HM; Haddock, DR; Schulz-Key, H | 1 |
| Taylor, HR | 1 |
| Goodwin, LG | 1 |
| Copeman, DB; Forsyth, KP; Mitchell, GF | 1 |
| Atwell, RB; Boreham, PF | 1 |
| Gaxotte, P; Glaziou, P; Moulia-Pelat, JP; Nguyen, LN; Nicolas, L; Weil, GJ | 1 |
| Assadi-Rad, AM; Burr, JH; Faulkner, CT; Patton, S; Reinemeyer, CR | 1 |
| Canton, P; Hulin, C; Kures, L; May, T; Neimann, L; Rabaud, C | 1 |
| Navaratnam, V | 1 |
| Breyer, S; Graninger, W; Wenisch, C; Wiesinger, E; Winkler, S | 1 |
| Cardines, R; Cartel, JL; Chanteau, S; Glaziou, P; Martin, PM; Moulia-Pelat, JP; Nguyen, LN; Ottesen, EA | 1 |
| Cartel, JL; Chanteau, S; Glaziou, P; Martin, PM; Moulia-Pelat, JP; Nguyen, LN | 1 |
| Ottesen, EA | 2 |
| Alpers, M; Day, K; Greenberg, J; Kazura, J; Perry, R; Weil, G | 1 |
| Kumaraswami, V; Rajan, K; Shenoy, RK; Thankom, S | 1 |
| Cartel, JL; Chanteau, S; Gay, VM; Glaziou, P; Martin, PM; Moulia-Pelat, JP; Nguyen, LN | 1 |
| Addiss, DG; Eberhard, ML; Lammie, PJ; Lee, SH; McNeeley, DF; McNeeley, MB; Spencer, HC | 1 |
| Boussinesq, M; Chippaux, JP; Ducorps, M; Gardon, J; Gardon-Wendel, N; Ndong, W; Ranque, S; Schneider, D | 1 |
| Hascoet, H; Moulia-Pelat, JP; Nguyen, LN; Nicolas, L | 1 |
| Kaiser, L; Maksimowich, DS; Williams, JF | 1 |
| Duarte, Z; Gantier, JC; Gayral, P | 1 |
| Moulia-Pelat, JP; Nguyen, LN; Nicolas, L; Plichart, C | 1 |
| Addiss, DG; Eberhard, ML; Hightower, AW; Lammie, PJ | 1 |
| Alexander, ND; Alpers, MP; Bockarie, F; Bockarie, MJ; Dimber, Z; Hyun, P; Ibam, E; Kazura, JW | 1 |
| Bricaire, F; Caumes, E; Danis, M; Datry, A; Gentilini, M; Nozais, JP | 1 |
| Behbehani, K; Duke, BO; Karam, M; Ottesen, EA | 1 |
| Langy, S; Luquiaud, P; Nicolas, L; Plichart, C; Williams, SA | 1 |
| George, LM; John, A; Kumaraswami, V; Shenoy, RK; Suma, TK | 1 |
| Kumaraswami, V; Rajan, K; Shenoy, RK; Suma, TK | 1 |
| Alley, ES; Boatin, BA; Dadzie, KY; Dembélé, N; Toé, L; Weiss, N | 1 |
| Deparis, X; Langy, S; Nicolas, L; Plichart, C | 1 |
| Takeuchi, T | 1 |
| Gopinath, R; Hanna, LE; Kavitha, V; Kumaraswami, V; Nutman, TB; Pillai, SV; Rajasekharan, A; Vijayasekaran, V | 1 |
| Horton, J; Ismail, MM; Ottesen, EA | 1 |
| Ismail, MM; Jayakody, RL | 1 |
| Dalia, S; John, A; Kumaraswami, V; Shenoy, RK; Suma, TK | 1 |
| Stingl, P | 1 |
| Babu, BS; John, A; Kumaraswami, V; Shenoy, RK; Suma, TK | 1 |
| Dreyer, G; Figueredo-Silva, J; Norões, J; Piessens, WF | 1 |
| Das, PK; Kala, S; Pani, SP; Subramanyam Reddy, G; Vanamail, P; Vengatesvarlou, N; Vijayan, AP | 1 |
| Stephenson, I; Wiselka, M | 1 |
| Addiss, DG; Eberhard, ML; Lammie, PJ; Schuetz, A | 1 |
| Addiss, DG; Awadzi, K; Beach, MJ; Belizario, VY; Dunyo, SK; Espinel, M; Gyapong, JO; Horton, J; Hossain, M; Ismail, MM; Jayakody, RL; Lammie, PJ; Lazdins, JK; Makunde, W; Ottesen, EA; Richard-Lenoble, D; Selve, B; Shenoy, RK; Simonsen, PE; Wamae, CN; Weerasooriya, MV; Witt, C | 1 |
| Gajanana, A; Hiriyan, J; Mani, TR; Rajendran, R; Reuben, R; Sunish, IP; Tewari, SC | 1 |
| Gajanana, A; Hiriyan, J; Mani, TR; Munirathinam, A; Rajendran, R; Satyanarayana, K; Sunish, IP; Tewari, SC | 1 |
| Awadzi, K; Keiser, PB; Nutman, TB; Ottesen, EA; Reynolds, SM; Taylor, MJ | 1 |
| Das, PK; Pani, SP; Ramaiah, KD; Vanamail, P; Yuvaraj, J | 2 |
| Alexander, ND; Alpers, MP; Bockarie, F; Bockarie, MJ; Dimber, Z; Ibam, E; Kastens, W; Kazura, JW; Tisch, DJ | 1 |
| Krishnamoorthy, K; Rajendran, R; Reuben, R; Sunish, IP | 1 |
| Curtis, CF; Malecela-Lazaro, M; Maxwell, CA; Reuben, R | 1 |
| Das, PK; Subramanian, S | 1 |
| Amarillo, ME; Belizario, VY; Bugayong, MG; de Leon, WU; de los Reyes, AE; Macatangay, BJ | 1 |
| Das, PK; Habbema, JD; Stolk, WA; Swaminathan, S; van Oortmarssen, GJ | 1 |
| Das, PK; Pani, SP; Ramaiah, KD; Vanamail, P | 3 |
| Addiss, D; Critchley, J; Ejere, H; Gamble, C; Garner, P; Gelband, H | 3 |
| Choochote, W; Jitpakdi, A; Na-Bangchang, K; Pitasawat, B; Riyong, D; Tippawangkosol, P | 2 |
| Melrose, WD | 1 |
| Das, PK; Pani, SP; Ramaiah, KD; Subramanian, S; Vanamail, P; Yuvaraj, J | 1 |
| McCarthy, J | 1 |
| Ahn, PJ; Bertagnolli, R; Fraser, SL; Freeman, JH | 1 |
| Bregani, ER; Magnini, MG; Mbaïdoum, N; Rovellini, A | 1 |
| DAS, PK; DE Vlas, SJ; Habbema, JD; Pani, SP; Stolk, WA; Subramanian, S; VAN Oortmarssen, GJ | 1 |
| Chansiri, G; Chansiri, K; Khawsak, P; Phantana, S; Sarataphan, N | 1 |
| Das, LK; Pani, SP; Reddy, GS; Vanamail, P; Venkatesvarlou, N; Vijayan, AP | 1 |
| Molyneux, DH | 1 |
| de Kraker, ME; Habbema, JD; Stolk, WA; van Oortmarssen, GJ | 1 |
| Dash, AP; Mani, TR; Munirathinam, A; Rajendran, R; Reuben, R; Sunish, IP | 1 |
| Basáñez, MG; Churcher, TS; Prichard, RK; Schwab, AE; Schwab, AJ | 1 |
| Dash, AP; Mani, TR; Munirathinam, A; Rajendran, R; Sunish, IP; Tyagi, BK | 1 |
| DAS, PK; Vanamail, P | 1 |
| Carron, J; Durrheim, DN; Gyapong, M; Melrose, WD; Wynd, S | 1 |
| Alpers, MP; Bockarie, MJ; Dimber, Z; Hazlett, FE; Kastens, W; Kazura, JW; Kiniboro, B; Tarongka, N; Tisch, DJ | 1 |
| Dhal, K; Kerketta, AS; Nayak, R | 1 |
| Munirathinam, A; Rajendran, R; Sunish, IP; Tyagi, BK | 1 |
| Bockarie, M; Hoerauf, A; Taylor, MJ | 1 |
| Das, MK; Laxmanappa, HS; Ramasamy, D; Sharma, R | 1 |
| Geary, TG; Mackenzie, CD | 1 |
| Gentil, K; Halliday, A; Hoerauf, A; Pearlman, E; Tamarozzi, F; Taylor, MJ | 1 |
| Beach, MJ; Boyd, A; Kucerova, Z; Lammie, PJ; Moss, DM; Priest, JW; Weinkopff, T | 1 |
| Baldelli, F; D'Annibale, ML; De Socio, GV; Papili, R; Sgrelli, A | 1 |
| Gupta, J; Misra, S; Misra-Bhattacharya, S; Sashidhara, KV; Singh, SP | 1 |
| Jambulingam, P; Krishnamoorthy, K; Nandha, B | 1 |
| Bockarie, MJ; Rebollo, MP | 1 |
| Addiss, DG; Beau de Rochars, VM; Blackstock, AJ; Eddy, BA; Fox, LM; Streit, TG; Williamson, JM | 1 |
| Metzger, WG; Mordmüller, B | 1 |
| Abidin, MZ; Afzal, M; Ahmad, FJ; Ali, M; Bhattacharya, SM; Dinda, AK; Samim, M; Verma, M | 1 |
| Fleckenstein, L; King, CL; Sanuku, N; Schmidt, MS; Siba, PM; Thomsen, EK | 1 |
| Brattig, NW; Castro-Corona, MA; García-Hernández, M; Medina-De la Garza, CE; Segoviano-Ramírez, JC | 1 |
| Ang, KH; Arkin, M; Bell, A; Bidlow, CM; Bulman, CA; Chen, S; Cho-Ngwa, F; Debnath, A; Franklin, C; Gut, J; Knudsen, GM; Lim, KC; Lustigman, S; Marcellino, C; McKerrow, JH; Rascón, AA; Sakanari, JA; Samje, M; Supakorndej, N; Supakorndej, P; Suzuki, B; Tricoche, N; Williams, D; Wilson, C; Wolfe, AR | 1 |
| Baea, M; Fleckenstein, LL; Kazura, JW; King, CL; Lombore, B; Maki, E; Sanuku, N; Satofan, S; Schmidt, MS; Siba, PM; Thomsen, EK; Weil, GJ | 1 |
| Katoch, D; Kumar, N; Kushwaha, V; Lal, B; Murthy, PK; Saxena, K; Singh, B; Verma, R; Verma, SK | 1 |
| de Vlas, SJ; Jambulingam, P; Stolk, WA; Subramanian, S; Vinubala, C | 1 |
| King, J; Mikhailov, A; Montresor, A; Mupfasoni, D | 1 |
| Hollingsworth, TD; Irvine, MA; Michael, E; Singh, BK; Smith, ME; Stolk, WA; Subramanian, S; Weil, GJ | 1 |
| Fischer, PU; Jacobson, JA; King, CL; Weil, GJ | 1 |
| Bopda, J; Fay, MP; Gounoue, R; Herrick, JA; Kamgno, J; Klion, AD; Legrand, F; Makiya, M; Metenou, S; Montavon, C; Nchinda, G; Nguluwe, K; Nutman, TB; Ondigui, BE; Tchana, SM | 1 |
| Derua, YA; Jones, C; Malecela, MN; Ngasalla, B; Tarimo, D | 1 |
| Basáñez, MG; Cano, J; O'Hanlon, SJ; Pullan, RL; Rebollo, MP; Tekle, AH; Wanji, S; Zouré, HG | 1 |
| Andersen, BJ; Budge, PJ; Herbert, C; Weil, GJ | 1 |
| Brown, P; de Vlas, SJ; de Vos, AS; Hollingsworth, TD; Irvine, MA; Kloek, M; Kontoroupis, P; Michael, E; Prada, JM; Smith, ME; Stolk, WA; Subramanian, S; Touloupou, P | 1 |
| Lorenz, WW; McCoy, CJ; Rada, B; Reaves, BJ; Wallis, C; Wolstenholme, AJ | 1 |
| Angheben, A; Bisoffi, Z; Bottieau, E; Bouchaud, O; Buonfrate, D; Calleri, G; Clerinx, J; Gobbi, F; Guerriero, M; Herrera-Ávila, JP; Neumayr, A; Rodari, P; Rojo-Marcos, G; Rothe, C; Salvador, F; Treviño, B; Zammarchi, L | 1 |
| Cheng, YC; Goss, CW; Kazura, JW; King, CL; Mancuso, B; Robinson, LJ; Sanuku, N; Satofan, S; Siba, PM; Suamani, J; Weil, GJ | 1 |
| Ahnn, J; Cho, JH; Choi, TW; Song, HO | 1 |
| Biritwum, NK; Idun, B; Mechan, F; Minetti, C; Osei-Atweneboana, MY; Prada, JM; Reimer, LJ; Tettevi, EJ | 1 |
| Budhathoki, SS; Garner, P; Johnson, S; Macfarlane, CL; Richardson, M | 1 |
| Geary, TG; Mackenzie, CD; Silber, SA | 1 |
| Bjerum, CM; Chhonker, YS; Edi, C; King, CL; Koudou, BG; Méité, A; Murry, DJ; Ouattara, AF; Penali, LK; Weil, GJ | 1 |
| Dubray, C; Fischer, PU; Goss, CW; Hardy, M; Jambulingam, P; King, CL; Laman, M; Lemoine, JF; O'Brian, K; Robinson, LJ; Samuela, J; Schechtman, KB; Subramanian, S; Supali, T; Weil, GJ | 1 |
| Andersen, BJ; Curtis, K; Fischer, PU; Hertz, MI; King, CL; Kupritz, J; Meite, A; Mitreva, M; Rosa, BA; Serge, T; Weil, GJ | 1 |
| Aboulaye, M; Andersen, BJ; Bjerum, CM; King, CL; Kouadio, O; Koudou, BG; Marius, VK; Ouattara, AF; Weil, GJ | 1 |
| Krishnamoorthy, K; Kuttiatt, VS; Purushothaman, J; Somani, RK; Swaminathan, S; Weil, GJ | 1 |
| Bouchaud, O; Bourée, P; Cailhol, J; Caumes, E; Dupouy Camet, J; Godineau, N; Loarec, A; Matheron, S; Poilane, I | 1 |
| Grobler, AC; Hardy, M; Kaldor, JM; Kama, M; King, CL; Robinson, LJ; Romani, L; Samuela, J; Steer, AC; Tuicakau, M; Weil, GJ; Whitfeld, MJ | 2 |
| Kazura, JW; King, CL; Weil, GJ | 1 |
| Beau de Rochars, VM; Bogus, J; Direny, AN; Dubray, CL; Ernest, JR; Fayette, CR; Goss, CW; Hast, M; Lemoine, JF; O'Brian, K; Pavilus, GE; Sabin, DF; Sircar, AD; Weil, GJ; Wiegand, RE | 1 |
| Das, PK; Hoti, SL; Jambulingam, P; Pani, SP; Sankari, T; Subramanian, S | 1 |
| Gass, K; Graves, PM; Kearns, T; Lau, CL; Mayfield, HJ; Naseri, T; Sheridan, S; Thomsen, R; Willis, GA | 1 |
| Horton, J; Ottesen, EA | 1 |
| Jacobson, JA; King, JD; Weil, GJ | 1 |
| Kibe, LW; Kimani, BW; Njomo, DW; Okoyo, C; Omondi, WP; Sultani, HM | 1 |
| Dwivedi, GP; Jambulingam, P; Krishnamoorthy, K; Kuttiatt, VS; Rahi, M; Raju, HKK; Somani, RK; Srividya, A; Subramanian, S; Suryaprakash, MK; Weil, GJ | 1 |
| Basker, N; Beau de Rochars, M; Bogus, J; Dilliott, D; Direny, AN; Dubray, C; Fischer, PU; Ga, AL; Goss, CW; Hardy, M; Howard, C; Jambulingam, P; King, CL; Krentel, A; Laman, M; Lemoine, JF; Mallya, S; Robinson, LJ; Samuela, J; Schechtman, KB; Steer, AC; Supali, T; Tavul, L; Weil, GJ | 1 |
| Aboulaye, M; Andersen, B; Bjerum, CM; Goss, CW; King, CL; Kouadio, O; Koudou, BG; Lew, D; Marius, VK; Ouattara, AF; Weil, GJ | 1 |
| Alfian, R; Bogus, J; Christian, M; Destani, Y; Djuardi, Y; Fischer, PU; Iskandar, E; Lew, D; Lomiga, A; Maylasari, R; Minggu, D; Supali, T; Weil, GJ | 1 |
| Dean, L; Dum-Buo, N; Fung, EG; Nji, TM; Ozano, K; Piotrowski, H; Theobald, S; Thomson, R; Wanji, S | 1 |
| Alexandre, JS; Burgert-Brucker, CR; Clementson, N; Cox, H; Dilliott, D; Harding-Esch, EM; Krentel, A; Morice Trejos, AC; Niles, RA; Sampson, A; Scholte, RGC; Thickstun, CR | 1 |
| Abd-Elsalam, S; Abdelazeem, B; Abuelazm, MT; Ashraf, M; Badr, H; Gamal, M | 1 |
| Amuga, M; Bieb, S; Bjerum, C; Goss, CW; Howard, C; John, LN; Karl, S; Kerry, Z; King, CL; Kotty, B; Kualawi, M; Kumai, S; Laman, M; Lorry, L; Makita, L; O'Brian, K; Pomat, W; Robinson, LJ; Samuel, A; Tavul, L; Tisch, DJ; Wangi, J; Weil, GJ | 1 |
| Ghosh, RS; Haldar, P; Jacobson, J | 1 |
| Jacobson, J; King, JD; Krentel, A | 1 |
| Bechu, V; Bhagirov, R; Brant, TA; Buhagiar, TS; Camacho, J; Chutaro, E; Dodd, E; Faktaufon, D; Hardy, M; Kaldor, J; Lepaitai, HB; Mani, J; Naqio, F; Naseri, T; Nua, MT; Otaki, J; Padmasiri, E; Rainima-Qaniuci, M; Romani, L; Samuela, J; Sekihara, M; Sosene, V; Steer, AC; Suiaunoa-Scanlan, L; Thean, LJ; Thomsen, R; Tufa, A; Utu, F; Won, KY; Yajima, A | 1 |
| Dhingra, N; Roy, N; Tripathi, B | 1 |
| Dubray, C; Fayette, C; Fischer, P; Hardy, M; Jambulingam, P; King, C; Krishnamoorthy, K; Laman, M; Lemoine, JF; Samuela, J; Subramanian, S; Supali, T; Weil, GJ | 1 |
| Fischer, PU; Krentel, A; Weil, GJ | 1 |
| Jacobson, J | 1 |
| Albert, JM; Bieb, S; Bjerum, CM; Howard, SC; John, L; Karl, S; Kerry, Z; King, CL; Kotty, B; Kumai, S; Laman, M; Lorry, L; Makita, L; Payne, M; Robinson, LJ; Samuel, A; Tavul, L; Timinao, L; Tisch, DJ; Wangi, J; Weil, GJ | 1 |
| Gayen, S; Jana, JK; Mandal, AK; Pal, AC | 1 |
| Glass, K; Graves, PM; Lau, C; McLure, A; Shaw, C | 1 |
| Cosano-Palma, E; López-Herrero, F; Montenegro-Quintana, MA; Pérez-García, MV; Sánchez-Vicente, JL; Sotomayor-Toribio, M | 1 |
| Amaral, S; Arkell, P; Clarke, NE; Engelman, D; Fancourt, N; Fernandes, JL; Francis, JR; Hii, SF; Kaldor, J; Le, B; Matthews, A; Monteiro, MAA; Nery, SV; Steer, A; Traub, R; Wand, H; Yan, J | 1 |
| Doe, F; Dubben, B; Fetcho, N; Fischer, K; Fischer, PU; Gordor, S; Goss, CW; Gyasi, ME; Hoerauf, A; Hong, AR; Kanza, E; King, CL; Laryea, R; Lew, D; Opoku, NO; Seidu, MA; Weil, GJ | 1 |
| Aklillu, E; Barry, A; Guantai, A; Khaemba, C; Kirui, E; Njenga, SM; Oluka, M; Omondi, WP; Parthasarathi, G | 1 |
| Diggle, PJ; Fronterre, C; Gass, K; Hundley, L; Morice, A; Niles-Robin, R; Sampson, A; Scholte, RC | 1 |
| Alshehri, A; Bala, V; Bjerum, C; Budge, PJ; Chhonker, YS; Fischer, PU; Gabo, TP; King, CL; Koudou, BG; Meïté, A; Murry, DJ; Ouattara, AF; Weil, GJ | 1 |
| Dinesh, RJ; Jambulingam, P; Krishnamoorthy, K; Kumar, A; Raghorte, MC; Sabesan, S; Srividya, A; Subramanian, S | 1 |
| Bjerum, CM; Budge, PJ; Fischer, PU; Gabo, PT; Goss, CW; King, CL; Koudou, BG; Lew, D; Ouattara, AF; Weil, GJ | 1 |
30 review(s) available for dextrothyroxine and diethylcarbamazine
| Article | Year |
|---|---|
Clinical pharmacokinetics of drugs against onchocerciasis.
Topics: Anthelmintics; Benzimidazoles; Diethylcarbamazine; Filaricides; Humans; Ivermectin; Onchocerciasis; Suramin; Trichlorfon | 1990 |
Onchocerciasis: an overview.
Topics: Diethylcarbamazine; Eye; Humans; Ivermectin; Onchocerciasis, Ocular; Suramin | 1990 |
Drug treatment of onchocerciasis.
Topics: Diethylcarbamazine; Humans; Ivermectin; Levamisole; Onchocerciasis; Suramin | 1988 |
Recent advances in research on filariasis. Chemotherapy.
Topics: Animals; Anti-Inflammatory Agents; Arsenicals; Benzimidazoles; Diethylcarbamazine; Drug Evaluation, Preclinical; Filariasis; Filaricides; Filarioidea; Humans; Ivermectin; Lactones; Onchocerciasis; Suramin | 1984 |
Recent advances in the chemotherapy of lymphatic filariasis.
Topics: Benzimidazoles; Benzothiazoles; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Thiabendazole; Thiazoles | 1993 |
[Short review of pathophysiology and therapeutic possibilities in onchocerciasis with reference to a case report].
Topics: Adult; Animals; Antibodies, Helminth; Diethylcarbamazine; Drug Therapy, Combination; Eosinophilia; Humans; Immunoglobulin E; Ivermectin; Male; Microfilariae; Onchocerca volvulus; Onchocerciasis; T-Lymphocytes | 1994 |
Filarial infections.
Topics: Adult; Diethylcarbamazine; Filariasis; Humans; Ivermectin | 1993 |
Strategies and tools for the control/elimination of lymphatic filariasis.
Topics: Adult; Africa; Albendazole; Animals; Anthelmintics; Asia; Child; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Microfilariae; Superinfection | 1997 |
Diagnostics in onchocerciasis: future challenges.
Topics: Animals; Antigens, Helminth; Diethylcarbamazine; Filaricides; Humans; Ivermectin; Microfilariae; Onchocerciasis; Parasitology; Polymerase Chain Reaction | 1998 |
[Onchocerciasis].
Topics: Animals; Antiparasitic Agents; Diagnosis, Differential; Diethylcarbamazine; Filaricides; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Prognosis; Skin Diseases, Parasitic | 1999 |
The role of albendazole in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Animals; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Male; Microfilariae; Patient Compliance; Public Health; Wuchereria bancrofti | 1999 |
Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective.
Topics: Albendazole; Animals; Anthelmintics; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Lymphangitis; Male; Models, Biological; Scrotum; Testicular Hydrocele; Wuchereria bancrofti | 2000 |
Drug treatment of tropical parasitic infections: recent achievements and developments.
Topics: Anthelmintics; Benzimidazoles; Diethylcarbamazine; Helminthiasis; Humans; Ivermectin; Malaria; Parasitic Diseases; Praziquantel; Schistosomiasis; Tropical Medicine; Trypanosomiasis | 2000 |
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Topics: Albendazole; Clinical Trials as Topic; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; National Health Programs; World Health Organization | 2000 |
Albendazole for lymphatic filariasis.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Randomized Controlled Trials as Topic | 2004 |
Chemotherapy for lymphatic filariasis: progress but not perfection.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Humans; Ivermectin; Wuchereria bancrofti | 2003 |
Albendazole for the control and elimination of lymphatic filariasis: systematic review.
Topics: Adult; Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Randomized Controlled Trials as Topic; Treatment Outcome | 2005 |
Albendazole for lymphatic filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Randomized Controlled Trials as Topic | 2005 |
Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Child; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Longevity; Microfilariae; Middle Aged; Models, Statistical; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome; Wuchereria bancrofti | 2006 |
Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature.
Topics: Albendazole; Community Health Services; Cultural Characteristics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Life Style; Prejudice | 2007 |
Lymphatic filariasis and onchocerciasis.
Topics: Africa South of the Sahara; Age Factors; Albendazole; Animals; Anti-Bacterial Agents; Antinematodal Agents; Blindness; Culicidae; Dermatitis; Dermatologic Agents; Diethylcarbamazine; Doxycycline; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Gram-Negative Bacterial Infections; Granuloma; Humans; India; Ivermectin; Lymphadenitis; Lymphangitis; Lymphedema; Macrolides; Onchocerciasis; Prevalence; Symbiosis; Wolbachia | 2010 |
Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment.
Topics: Animals; Diethylcarbamazine; Filaricides; Humans; Inflammation; Ivermectin; Onchocerca volvulus; Onchocerciasis, Ocular; Symbiosis; Wolbachia | 2011 |
[Loa loa filariasis in Italy: review of the literature with a clinical report].
Topics: Adult; Albendazole; Animals; Antinematodal Agents; Diethylcarbamazine; Diptera; Drug Therapy, Combination; Eosinophilia; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Treatment Outcome | 2011 |
Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.
Topics: Albendazole; Anthelmintics; Chemoprevention; Diethylcarbamazine; Disease Eradication; Elephantiasis, Filarial; Epidemiological Monitoring; Humans; Ivermectin; Models, Theoretical | 2013 |
Loa loa-does it deserve to be neglected?
Topics: Albendazole; Diethylcarbamazine; Filaricides; Humans; Ivermectin; Loiasis | 2014 |
Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin | 2018 |
Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.
Topics: Albendazole; Antigens, Helminth; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Randomized Controlled Trials as Topic | 2019 |
Flubendazole as a macrofilaricide: History and background.
Topics: Albendazole; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Gastrointestinal Diseases; Humans; Ivermectin; Mebendazole; Microfilariae; Onchocerca volvulus; Onchocerciasis; Wuchereria bancrofti | 2019 |
Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875-2000).
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin | 2020 |
Efficacy and safety of triple therapy versus dual therapy for lymphatic filariasis: A systematic review and meta-analysis.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Microfilariae | 2022 |
74 trial(s) available for dextrothyroxine and diethylcarbamazine
| Article | Year |
|---|---|
[Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitological observations].
Topics: Adolescent; Adult; Aged; Animals; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Female; Fever; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Recurrence; Wuchereria bancrofti | 1992 |
[Ivermectin or diethylcarbamazine in spaced dosages in Bancroft's filariasis: which protocol?].
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis, Filarial; Humans; Ivermectin; Male; Middle Aged; Wuchereria bancrofti | 1992 |
Ivermectin and diethylcarbamazine trials in leaf monkeys (Presbytis cristatus) infected with Wuchereria kalimantani.
Topics: Animals; Cercopithecidae; Diethylcarbamazine; Haplorhini; Ivermectin; Microfilariae; Parasitic Diseases; Placebos; Wuchereria | 1992 |
[Comparative efficacy of annual and semi-annual doses of ivermectin or diethylcarbamazine for the prevention of lymphatic filariasis].
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Dose-Response Relationship, Drug; Double-Blind Method; Elephantiasis; Humans; Ivermectin; Male; Middle Aged; Wuchereria bancrofti | 1992 |
Compared efficacy of repeated annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia. Final evaluation.
Topics: Adult; Animals; Carrier State; Diethylcarbamazine; Double-Blind Method; Drug Evaluation; Elephantiasis, Filarial; Follow-Up Studies; Humans; Ivermectin; Microfilariae; Middle Aged; Polynesia; Wuchereria bancrofti | 1992 |
Alterations in filarial antigen-specific immunologic reactivity following treatment with ivermectin and diethylcarbamazine.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Diethylcarbamazine; Double-Blind Method; Female; Filariasis; Filarioidea; Humans; Immunity, Cellular; Ivermectin; Longitudinal Studies; Lymphocyte Activation; Male; Microfilariae | 1992 |
Kinetics of circulating human IgG4 after diethylcarbamazine and ivermectin treatment of bancroftian filariasis.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Follow-Up Studies; Humans; Immunoglobulin G; Ivermectin; Kinetics; Microfilariae; Wuchereria bancrofti | 1992 |
Single versus repeated doses of ivermectin and diethylcarbamazine for the treatment of Wuchereria bancrofti var. pacifica microfilaremia. Results at 12 months of a double-blind study.
Topics: Adult; Animals; Carrier State; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis, Filarial; Humans; Ivermectin; Microfilariae; Middle Aged; Wuchereria bancrofti | 1991 |
Cumulative mortality rates in Aedes polynesiensis after feeding on polynesian Wuchereria bancrofti carriers treated with single doses of ivermectin, diethylcarbamazine and placebo.
Topics: Aedes; Animals; Carrier State; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Humans; Insect Vectors; Ivermectin; Probability; Wuchereria bancrofti | 1991 |
Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitologic observations.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Recurrence; Wuchereria bancrofti | 1991 |
The treatment of microfilaremia due to Wuchereria bancrofti var. pacifica: ivermectin versus diethylcarbamazine.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Ivermectin; Male; Middle Aged; Polynesia; Wuchereria bancrofti | 1991 |
Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti.
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Double-Blind Method; Drug Tolerance; Elephantiasis, Filarial; Female; Follow-Up Studies; Haiti; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Wuchereria bancrofti | 1991 |
Double blind study on efficacy and safety of single doses of ivermectin and diethylcarbamazine for treatment of Polynesian Wuchereria bancrofti carriers. Results at six months.
Topics: Adult; Animals; Carrier State; Diethylcarbamazine; Dose-Response Relationship, Drug; Double-Blind Method; Elephantiasis, Filarial; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Wuchereria bancrofti | 1991 |
A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.
Topics: Adult; Animals; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis, Filarial; Filariasis; Humans; Ivermectin; Male; Middle Aged; Randomized Controlled Trials as Topic; Wuchereria bancrofti | 1990 |
[Effects of diethylcarbamazine and ivermectin on the mobilization of microfilariae of Onchocerca volvulus].
Topics: Adult; Animals; Diethylcarbamazine; Double-Blind Method; Filarioidea; Humans; Ivermectin; Mali; Microfilariae; Onchocerciasis; Placebos | 1989 |
Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.
Topics: Adolescent; Adult; Aged; Anthelmintics; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Eye Diseases; Filaricides; Humans; Ivermectin; Keratitis; Lactones; Male; Middle Aged; Onchocerca; Onchocerciasis; Random Allocation; Skin | 1985 |
Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
Topics: Adult; Animals; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Blind Method; Eye Diseases; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Skin; Skin Diseases, Parasitic; Urine | 1988 |
A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis.
Topics: Adolescent; Adult; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Eye Diseases; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerciasis; Pruritus; Skin | 1986 |
Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.
Topics: Adult; Anthelmintics; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Eye; Eye Diseases; Humans; Ivermectin; Lactones; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Random Allocation; Retina; Time Factors | 1986 |
[Senegalese experience with the efficacy of ivermectin (MK 933) in the treatment of human onchocerciasis (double-blind comparative study with diethylcarbamazine citrate) (DEC.C)].
Topics: Adolescent; Adult; Anthelmintics; Diethylcarbamazine; Filaricides; Humans; Ivermectin; Lactones; Male; Middle Aged; Onchocerciasis | 1986 |
The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerciasis; Skin; Time Factors | 1986 |
Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Blind Method; Eye Diseases; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerciasis; Time Factors | 1987 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Diethylcarbamazine; Double-Blind Method; Eye Diseases; Filaricides; Humans; Ivermectin; Lactones; Male; Middle Aged; Onchocerciasis; Random Allocation; Skin; Skin Diseases, Parasitic; Time Factors | 1985 |
An ocular reaction index for use in the study of onchocerciasis.
Topics: Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Blind Method; Eye; Humans; Ivermectin; Lactones; Male; Onchocerca; Onchocerciasis | 1985 |
Ivermectin in onchocerciasis.
Topics: Adolescent; Adult; Diethylcarbamazine; Humans; Ivermectin; Lactones; Male; Middle Aged; Onchocerciasis | 1984 |
Combination ivermectin plus diethylcarbamazine, a new effective tool for control of lymphatic filariasis.
Topics: Animals; Carrier State; Diethylcarbamazine; Double-Blind Method; Drug Therapy, Combination; Filariasis; Follow-Up Studies; Humans; Ivermectin; Male; Time Factors; Wuchereria bancrofti | 1995 |
Comparison of the efficacies of three heartworm preventives against experimentally induced infections with Ancylostoma caninum and Toxocara canis in pups.
Topics: Age Factors; Analysis of Variance; Ancylostomiasis; Animals; Anthelmintics; Anti-Bacterial Agents; Benzimidazoles; Diethylcarbamazine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Ivermectin; Macrolides; Male; Parasite Egg Count; Pyrantel; Toxocariasis | 1995 |
Ivermectin plus diethylcarbamazine: an additive effect on early microfilarial clearance.
Topics: Animals; Carrier State; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Humans; Ivermectin; Kinetics; Male; Microfilariae; Wuchereria bancrofti | 1994 |
Long-term efficacy of single-dose treatment with 400 micrograms.kg-1 of ivermectin in bancroftian filariasis: results at one year.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Follow-Up Studies; Humans; Ivermectin; Male; Microfilariae; Recurrence; Wuchereria bancrofti | 1993 |
Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea.
Topics: Adult; Animals; Antigens, Helminth; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Follow-Up Studies; Humans; Ivermectin; Lymph Nodes; Male; Microfilariae; Papua New Guinea; Wuchereria bancrofti | 1993 |
A comparative study of the efficacy and tolerability of single and split doses of ivermectin and diethylcarbamazine in periodic brugian filariasis.
Topics: Adolescent; Adult; Animals; Brugia; Diethylcarbamazine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Elephantiasis, Filarial; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Periodicity; Time Factors | 1993 |
Safety trial of single-dose treatments with a combination of ivermectin and diethylcarbamazine in bancroftian filariasis.
Topics: Adult; Aged; Animals; Carrier State; Diethylcarbamazine; Dose-Response Relationship, Drug; Drug Combinations; Elephantiasis, Filarial; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Time Factors; Wuchereria bancrofti | 1993 |
[Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine: immunological observation].
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Humans; Ivermectin; Wuchereria bancrofti | 1993 |
Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia.
Topics: Adolescent; Adult; Aged; Animals; Circadian Rhythm; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Drug Tolerance; Elephantiasis, Filarial; Female; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Wuchereria bancrofti | 1993 |
[Combinations of ivermectin and diethylcarbamazine for improved control of lymphatic filariasis].
Topics: Adult; Aged; Communicable Disease Control; Diethylcarbamazine; Double-Blind Method; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Male; Middle Aged; Time Factors | 1996 |
Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
Topics: Adolescent; Adult; Animals; Anopheles; Child; Child, Preschool; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Insect Vectors; Ivermectin; Male; Papua New Guinea; Wuchereria bancrofti | 1998 |
Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb.
Topics: Acute Disease; Adult; Animals; Antinematodal Agents; Brugia malayi; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Female; Humans; Ivermectin; Lymphangitis; Male | 1998 |
Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka.
Topics: Adolescent; Albendazole; Antinematodal Agents; Child; Child, Preschool; Diethylcarbamazine; Drug Combinations; Feces; Female; Humans; Ivermectin; Male; Parasite Egg Count; Trichuriasis | 1999 |
Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Brugia malayi; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Parasitemia; Treatment Outcome | 1999 |
Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Brugia malayi; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; Female; Filariasis; Filaricides; Follow-Up Studies; Humans; Ivermectin; Male; Middle Aged; Parasitemia; Treatment Outcome | 2000 |
Tolerability and efficacy of single-dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India.
Topics: Adult; Animals; Carrier State; Diethylcarbamazine; Double-Blind Method; Female; Filariasis; Filaricides; Humans; India; Ivermectin; Male; Treatment Outcome; Wuchereria bancrofti | 2000 |
Annual single-dose diethylcarbamazine plus ivermectin for control of bancroftian filariasis: comparative efficacy with and without vector control.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Culex; Diethylcarbamazine; Disease Vectors; Endemic Diseases; Female; Filariasis; Filaricides; Health Knowledge, Attitudes, Practice; Humans; India; Ivermectin; Male; Middle Aged; Odds Ratio; Prevalence; Rural Health; Statistics, Nonparametric; Treatment Outcome; Water Microbiology; Wuchereria bancrofti | 2001 |
Resurgence in filarial transmission after withdrawal of mass drug administration and the relationship between antigenaemia and microfilaraemia--a longitudinal study.
Topics: Adolescent; Adult; Animals; Antigens, Helminth; Child; Child, Preschool; Culex; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; Filariasis; Filaricides; Humans; Ivermectin; Microfilariae; Middle Aged; Mosquito Control; Wuchereria bancrofti | 2002 |
The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination.
Topics: Animals; Community Health Services; Culex; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis, Filarial; Female; Filaricides; Humans; India; Ivermectin; Male; Prevalence; Preventive Health Services; Rural Health; Treatment Outcome; Wuchereria bancrofti | 2002 |
Mass treatment to eliminate filariasis in Papua New Guinea.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Culicidae; Diethylcarbamazine; Disease Reservoirs; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Lymphedema; Male; Papua New Guinea; Prospective Studies; Testicular Hydrocele; Wuchereria bancrofti | 2002 |
A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp.
Topics: Adolescent; Albendazole; Anthelmintics; Ascariasis; Child; Diethylcarbamazine; Drug Therapy, Combination; Humans; Ivermectin; Philippines; Placebos; Single-Blind Method; Treatment Outcome; Trichuriasis | 2003 |
The prevalences of Wuchereria bancrofti antigenaemia in communities given six rounds of treatment with diethylcarbamazine, ivermectin or placebo tablets.
Topics: Animals; Antigens, Helminth; Child, Preschool; Diagnostic Tests, Routine; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Female; Filariasis; Filaricides; Humans; India; Infant; Ivermectin; Male; Placebos; Prevalence; Rural Health; Wuchereria bancrofti | 2003 |
The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
Topics: Animals; Culex; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis, Filarial; Filaricides; Humans; Insect Vectors; Ivermectin; Rural Health; Wuchereria bancrofti | 2003 |
Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.
Topics: Adult; Animals; Diethylcarbamazine; Double-Blind Method; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Microfilariae; Models, Biological; Treatment Outcome; Wuchereria bancrofti | 2005 |
Tolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India.
Topics: Adolescent; Adult; Animals; Antiparasitic Agents; Diethylcarbamazine; Double-Blind Method; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; India; Ivermectin; Male; Microfilariae; Parasitemia; Treatment Outcome; Wuchereria bancrofti | 2004 |
Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; India; Ivermectin; Male; Rural Population; Wuchereria bancrofti | 2006 |
Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
Topics: Animals; Child; Child, Preschool; Diethylcarbamazine; Double-Blind Method; Drug Administration Schedule; Elephantiasis, Filarial; Female; Filaricides; Humans; India; Infant; Ivermectin; Male; Preventive Health Services; Wuchereria bancrofti | 2007 |
Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Antiparasitic Agents; Child; Child, Preschool; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Follow-Up Studies; Humans; Infant; Ivermectin; Papua New Guinea; Wuchereria bancrofti | 2008 |
Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis.
Topics: Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Child; Child, Preschool; Diethylcarbamazine; Elephantiasis, Filarial; Haiti; Humans; Immunoassay; Immunoglobulin G; Ivermectin | 2011 |
Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Papua New Guinea; Parasitemia; Pilot Projects; Serum; Single-Blind Method; Treatment Outcome; Wuchereria bancrofti; Young Adult | 2016 |
Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.
Topics: Adult; Aged; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; Female; Filaricides; Humans; Ivermectin; Loiasis; Male; Middle Aged; Pilot Projects; Young Adult | 2017 |
Comparison of different drug regimens for the treatment of loiasis-A TropNet retrospective study.
Topics: Adult; Albendazole; Animals; Diethylcarbamazine; Europe; Filaricides; Humans; Ivermectin; Loa; Loiasis; Male; Retrospective Studies; Travel; Tropical Medicine; Young Adult | 2018 |
A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.
Topics: Adolescent; Adult; Albendazole; Animals; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Parasite Load; Single-Blind Method; Wuchereria bancrofti; Young Adult | 2018 |
Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Cohort Studies; Cote d'Ivoire; Diethylcarbamazine; Drug Combinations; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Treatment Outcome; Wuchereria bancrofti; Young Adult | 2019 |
Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach.
Topics: Adolescent; Adult; Body Height; Body Weight; Child; Cohort Studies; Diethylcarbamazine; Drug Dosage Calculations; Elephantiasis, Filarial; Female; Filaricides; Global Health; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Models, Statistical; Prevalence; Regression Analysis; Waist-Height Ratio; Young Adult | 2019 |
Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis.
Topics: Adolescent; Adult; Aged; Albendazole; Antigens, Helminth; Cytokines; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Young Adult | 2019 |
Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d'Ivoire: An Open-label Randomized Controlled Trial.
Topics: Albendazole; Animals; Cote d'Ivoire; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Ivermectin; Wuchereria bancrofti | 2020 |
The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Antiparasitic Agents; Child; Child, Preschool; Community-Acquired Infections; Diethylcarbamazine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Elephantiasis, Filarial; Female; Fiji; Helminthiasis; Humans; Infant; Insecticides; Ivermectin; Male; Middle Aged; Neglected Diseases; Rural Population; Scabies; Treatment Outcome; Young Adult | 2020 |
Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
Topics: Adolescent; Adult; Albendazole; Animals; Antiparasitic Agents; Child; Child, Preschool; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Haiti; Humans; Ivermectin; Logistic Models; Male; Mass Drug Administration; Middle Aged; Prevalence; Treatment Outcome; Young Adult | 2020 |
Heterogeneous response of Wuchereria bancrofti-infected persons to diethylcarbamazine (DEC) and its implications for the Global Programme to Eliminate Lymphatic Filariasis (GPELF).
Topics: Albendazole; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Logistic Models; Male; Microfilariae; Wuchereria bancrofti | 2021 |
An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
Topics: Adolescent; Adult; Albendazole; Animals; Child; Diethylcarbamazine; Drug-Related Side Effects and Adverse Reactions; Elephantiasis, Filarial; Female; Filaricides; Humans; India; Ivermectin; Male; Mass Drug Administration; Wuchereria bancrofti | 2021 |
A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.
Topics: Adolescent; Adult; Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Focus Groups; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Patient Acceptance of Health Care; Professionalism; Surveys and Questionnaires | 2021 |
Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire.
Topics: Albendazole; Animals; Cote d'Ivoire; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Ivermectin; Wuchereria bancrofti | 2022 |
Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial.
Topics: Albendazole; Animals; Australia; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Fiji; Filaricides; Humans; Ivermectin; Mass Drug Administration; Wuchereria bancrofti | 2021 |
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Antibodies, Protozoan; Asymptomatic Diseases; Brugia; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Indonesia; Ivermectin; Male; Microfilariae; Middle Aged; Treatment Outcome; Young Adult | 2021 |
Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Child; Child, Preschool; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Mass Drug Administration; Middle Aged; Papua New Guinea; Treatment Outcome; Wuchereria bancrofti; Young Adult | 2022 |
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
Topics: Albendazole; Cross-Sectional Studies; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Mass Drug Administration; Papua New Guinea | 2022 |
A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Onchocerciasis; Pilot Projects | 2023 |
Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study.
Topics: Adult; Albendazole; Animals; Cote d'Ivoire; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Wuchereria bancrofti | 2023 |
98 other study(ies) available for dextrothyroxine and diethylcarbamazine
| Article | Year |
|---|---|
[Value of ivermectin in the initial treatment of loaiasis].
Topics: Diethylcarbamazine; Female; Humans; Ivermectin; Loiasis; Male | 1991 |
Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. II. Immunologic changes following treatment.
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; Antigens, Helminth; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Hypersensitivity, Immediate; Interleukins; Ivermectin; Male; Microfilariae; Middle Aged; Tumor Necrosis Factor-alpha; Wuchereria bancrofti | 1991 |
Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin.
Topics: Animals; Antigens, Helminth; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Ivermectin; Microfilariae; Wuchereria bancrofti | 1991 |
Ivermectin inhibits molting of Wuchereria bancrofti third stage larvae in vitro.
Topics: Animals; Culture Media; Diethylcarbamazine; Dose-Response Relationship, Drug; Humans; Ivermectin; Larva; Wuchereria bancrofti | 1991 |
A new technique of in vitro assay of antifilarials using different life-forms of Acanthocheilonema viteae.
Topics: Animals; Anthelmintics; Diethylcarbamazine; Dipetalonema; Drug Evaluation, Preclinical; Filaricides; In Vitro Techniques; Ivermectin; Levamisole; Mebendazole; Parasite Egg Count; Piperazines | 1990 |
Bancroftian filariasis and ivermectin.
Topics: Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Ivermectin; Male; Wuchereria bancrofti | 1990 |
[Current possibilities in the control of Loa Loa filariasis].
Topics: Animals; Diethylcarbamazine; Diptera; Ecology; Humans; Insect Control; Ivermectin; Loa; Loiasis | 1990 |
Experimental ocular onchocerciasis: local and systemic antibody and cell-mediated immune responses.
Topics: Animals; Antibodies, Helminth; Cornea; Diethylcarbamazine; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Guinea Pigs; Immunity, Cellular; Immunoglobulin A; Immunoglobulin G; Immunohistochemistry; Ivermectin; Lymphocyte Activation; Lymphoid Tissue; Microfilariae; Onchocerca; Onchocerciasis, Ocular | 1990 |
Ivermectin and prothrombin time.
Topics: Administration, Oral; Adult; Animals; Diethylcarbamazine; Elephantiasis, Filarial; Filariasis; Humans; Ivermectin; Prothrombin Time; Wuchereria bancrofti | 1989 |
Lectin binding to the developing forms of Onchocerca gutturosa microfilariae.
Topics: Animals; Cattle; Chitinases; Diethylcarbamazine; Female; Ivermectin; Lectins; Microbial Collagenase; Microfilariae; Onchocerca; Peptide Hydrolases; Skin; Trypsin; Uterus | 1987 |
Autoantibody induced by experimental Onchocerca infection. Effect of different routes of administration of microfilariae and of treatment with diethylcarbamazine citrate and ivermectin.
Topics: Animals; Antibodies, Helminth; Autoantibodies; Corneal Diseases; Diethylcarbamazine; Enzyme-Linked Immunosorbent Assay; Guinea Pigs; Immunoglobulin G; Ivermectin; Keratitis; Male; Microfilariae; Onchocerca; Onchocerciasis | 1988 |
Clinical pharmacology looks at tropical medicine.
Topics: Amodiaquine; Anthelmintics; Antimalarials; Chloroquine; Diethylcarbamazine; Filariasis; Filaricides; Humans; Ivermectin; Malaria; Primaquine | 1987 |
[Loaiasis and its therapeutic difficulties].
Topics: Diethylcarbamazine; Eye Diseases; Filariasis; Humans; Ivermectin; Loiasis | 1986 |
Evaluation of drugs against Onchocerca microfiliariae in an inbred mouse model.
Topics: Animals; Anthelmintics; Diethylcarbamazine; Disease Models, Animal; Drug Evaluation, Preclinical; Elapid Venoms; Female; Filaricides; Ivermectin; Lactones; Lymphocyte Depletion; Mice; Mice, Inbred CBA; Microfilariae; Onchocerciasis; Skin; T-Lymphocytes | 1986 |
Anthelmintic drugs.
Topics: Amidines; Animals; Anthelmintics; Benzimidazoles; Cats; Cattle; Diethylcarbamazine; Dogs; Helminthiasis; Helminthiasis, Animal; Horses; Ivermectin; Lactones; Levamisole; Morantel; Organophosphorus Compounds; Piperazine; Piperazines; Praziquantel; Pyrantel; Salicylanilides; Sheep; Tetramisole | 1986 |
Recent developments in the treatment of onchocerciasis.
Topics: Antiprotozoal Agents; Benzimidazoles; Diethylcarbamazine; Humans; Ivermectin; Lactones; Onchocerciasis; Suramin | 1984 |
Onchocerca gibsoni: increase of circulating egg antigen with chemotherapy in bovines.
Topics: Animals; Anthelmintics; Antibodies, Monoclonal; Antigens, Surface; Cattle; Diethylcarbamazine; Female; Filaricides; Isothiocyanates; Ivermectin; Lactones; Male; Mebendazole; Onchocerca; Onchocerciasis; Ovum; Piperazines; Praziquantel; Thiocyanates | 1984 |
Absence of shock-like reactions to ivermectin in dogs infected with Dirofilaria immitis.
Topics: Animals; Anthelmintics; Diethylcarbamazine; Dirofilariasis; Dog Diseases; Dogs; Ivermectin; Lactones; Shock, Septic | 1983 |
[Pulmonary involvement with a favorable course during Loa loa filariasis].
Topics: Cameroon; Diethylcarbamazine; Humans; Ivermectin; Loiasis; Lung Diseases, Parasitic; Male; Middle Aged; Radiography | 1994 |
[Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Topics: Adult; Aged; Animals; Arthralgia; C-Reactive Protein; Cameroon; Diethylcarbamazine; Female; Fever; Filaricides; Headache; Hematuria; Humans; Ivermectin; Loa; Loiasis; Male; Microfilariae; Middle Aged; Onchocerciasis; Parasitemia; Proteinuria; Pruritus | 1995 |
Thiacetarsamide depresses relaxation of canine pulmonary artery in vitro.
Topics: Animals; Anthelmintics; Arsenamide; Diethylcarbamazine; Dirofilariasis; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Filaricides; In Vitro Techniques; Ivermectin; Methacholine Chloride; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Parasympathomimetics; Pulmonary Artery; Random Allocation; Vasodilator Agents | 1996 |
Activity of albendazole-ivermectin combination and other filaricidal drugs against infective larvae, preadult, microfilariae and adult worms of Molinema dessetae in the rodent Proechimys oris.
Topics: Administration, Oral; Albendazole; Animals; Diethylcarbamazine; Drug Combinations; Female; Filariasis; Filaricides; Filarioidea; Injections, Subcutaneous; Ivermectin; Larva; Male; Microfilariae; Rodent Diseases; Rodentia; Suramin | 1994 |
Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia.
Topics: Adult; Animals; Antigens, Helminth; Biomarkers; Diethylcarbamazine; Drug Therapy, Combination; Filariasis; Filaricides; Humans; Ivermectin; Polynesia; Prevalence; Seroepidemiologic Studies; Wuchereria bancrofti | 1997 |
Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin.
Topics: Adolescent; Adult; Aged; Animals; Antigens, Helminth; Child; Diethylcarbamazine; Female; Filariasis; Filaricides; Humans; Ivermectin; Male; Middle Aged; Wuchereria bancrofti | 1997 |
[Apropos of 5 new cases of onchocerciasis edema].
Topics: Animals; Arm; Cameroon; Cote d'Ivoire; Diethylcarbamazine; Edema; Eosinophilia; Fluorescent Antibody Technique, Indirect; Humans; Immunoelectrophoresis; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Serologic Tests; Skin | 1997 |
The immunodominant Brugia malayi paramyosin as a marker of current infection with Wuchereria bancrofti adult worms.
Topics: Adult; Animals; Antibodies, Helminth; Antigens, Helminth; Biomarkers; Brugia malayi; Diethylcarbamazine; DNA, Complementary; Filariasis; Filaricides; Glutathione Transferase; Helminth Proteins; Humans; Immunodominant Epitopes; Ivermectin; Molecular Sequence Data; Peptide Fragments; Polynesia; Recombinant Fusion Proteins; Treatment Outcome; Tropomyosin; Wuchereria bancrofti | 1998 |
Treatment of microfilaraemia in asymptomatic brugian filariasis: the efficacy and safety of the combination of single doses of ivermectin and diethylcarbamazine.
Topics: Adolescent; Adult; Animals; Antinematodal Agents; Brugia malayi; Diethylcarbamazine; Drug Therapy, Combination; Filariasis; Humans; Ivermectin; Male; Microfilariae; Middle Aged; Treatment Outcome | 1998 |
Filarial antibody responses in Wuchereria bancrofti transmission area are related to parasitological but not clinical status.
Topics: Adult; Aged; Animals; Antibodies, Helminth; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Humans; Immunoglobulin Isotypes; Ivermectin; Male; Middle Aged; Wuchereria bancrofti | 1999 |
Long-term persistence of cellular hyporesponsiveness to filarial antigens after clearance of microfilaremia.
Topics: Adult; Animals; Antigens, Helminth; Diethylcarbamazine; Drug Therapy, Combination; Female; Filariasis; Filaricides; Humans; Interferon-gamma; Interleukin-5; Ivermectin; Leukocytes, Mononuclear; Male; Microfilariae; Parasitemia; Tuberculin; Wuchereria bancrofti | 1999 |
[Elephantiasis soon eliminated? New therapeutic concepts make mass treatment possible].
Topics: Albendazole; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis; Filaricides; Humans; Ivermectin | 2000 |
Evaluation of the whole blood filariasis ICT test for short-term monitoring after antifilarial treatment.
Topics: Animals; Antigens, Helminth; Chromatography; Diethylcarbamazine; Filariasis; Filaricides; Humans; Ivermectin; Wuchereria bancrofti | 2000 |
Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions.
Topics: Adolescent; Adult; Calcium-Binding Proteins; Calgranulin B; Diethylcarbamazine; DNA, Bacterial; Filaricides; Humans; Ivermectin; Leukocyte L1 Antigen Complex; Male; Membrane Glycoproteins; Neural Cell Adhesion Molecules; Onchocerciasis; Symbiosis; Wolbachia | 2002 |
Major progress toward eliminating lymphatic filariasis.
Topics: Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin | 2002 |
Cost-effectiveness of the use of vector control and mass drug administration, separately or in combination, against lymphatic filariasis.
Topics: Animals; Cost-Benefit Analysis; Culex; Diethylcarbamazine; Disease Vectors; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Humans; India; Ivermectin; Mosquito Control; Rural Health; Wuchereria bancrofti | 2002 |
Use of floating layers of polystyrene beads to control populations of the filaria vector Culex quinquefasciatus.
Topics: Animals; Culex; Diethylcarbamazine; Disease Vectors; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Humans; India; Ivermectin; Larva; Mosquito Control; Polystyrenes; Prevalence; Rural Health; Tanzania; Wuchereria bancrofti | 2002 |
Modelling the epidemiology, transmission and control of lymphatic filariasis.
Topics: Animals; Computer Simulation; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Models, Biological; Mosquito Control; Population Dynamics; Prevalence; Reproducibility of Results; Treatment Outcome; Wuchereria bancrofti | 2002 |
Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis.
Topics: Adverse Drug Reaction Reporting Systems; Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Global Health; Humans; International Cooperation; Ivermectin; Population Surveillance; Program Development; Wuchereria bancrofti | 2003 |
Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
Topics: Albendazole; Animals; Computer Simulation; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; India; Ivermectin; Models, Biological; Models, Statistical; Prevalence; Wuchereria bancrofti | 2003 |
The in vitro effect of albendazole, ivermectin, diethylcarbamazine, and their combinations against infective third-stage larvae of nocturnally subperiodic Brugia malayi (Narathiwat strain): scanning electron microscopy.
Topics: Albendazole; Animals; Anthelmintics; Antinematodal Agents; Brugia malayi; Circadian Rhythm; Diethylcarbamazine; Filariasis; Filaricides; Ivermectin; Larva; Microscopy, Electron, Scanning; Movement; Toxicity Tests | 2004 |
Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
Topics: Albendazole; Developing Countries; Diethylcarbamazine; Disease Outbreaks; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Global Health; Humans; Ivermectin; Prevalence; Sentinel Surveillance | 2004 |
Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.
Topics: Animals; Chi-Square Distribution; Cohort Studies; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis, Filarial; Fever; Filaricides; Humans; India; Ivermectin; Nausea; Patient Compliance; Preventive Health Services; Program Evaluation; Rural Population; Wuchereria bancrofti | 2005 |
Comparative assessment of the in vitro sensitivity of Brugia malayi infective larvae to albendazole, diethylcarbamazine and ivermectin alone and in combination.
Topics: Albendazole; Animals; Anthelmintics; Antinematodal Agents; Brugia malayi; Diethylcarbamazine; Filaricides; In Vitro Techniques; Ivermectin; Movement; Statistics, Nonparametric; Toxicity Tests | 2004 |
Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
Topics: Albendazole; Animals; Anthelmintics; Diethylcarbamazine; Drug Resistance; Drug Therapy, Combination; Elephantiasis, Filarial; Humans; Ivermectin; Tubulin; Wuchereria bancrofti | 2005 |
Distended thoracic duct and diffuse lymphangiectasia caused by bancroftian filariasis.
Topics: Adult; Animals; Anthelmintics; Diethylcarbamazine; Filariasis; Humans; Ivermectin; Lymphangiectasis; Magnetic Resonance Imaging; Male; Thoracic Duct; Tomography, X-Ray Computed; Wuchereria bancrofti | 2005 |
Comparison of different anthelminthic drug regimens against Mansonella perstans filariasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Case-Control Studies; Chad; Child; Developing Countries; Diethylcarbamazine; Female; Filaricides; Humans; Ivermectin; Male; Mansonella; Mansonelliasis; Mebendazole; Middle Aged; Praziquantel; Statistics, Nonparametric; Thiabendazole; Treatment Outcome | 2006 |
The efficacy of a single-oral-dose administration of ivermectin and diethylcarbamazine on the treatment of feline Brugia malayi.
Topics: Animals; Anthelmintics; Base Sequence; Brugia malayi; Cat Diseases; Cats; Diethylcarbamazine; DNA Primers; Female; Filariasis; Ivermectin; Male; Thailand; Treatment Outcome | 2005 |
Elimination of transmission of lymphatic filariasis in Egypt.
Topics: Albendazole; Animals; Culex; Diethylcarbamazine; Disease Vectors; Egypt; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Public Health; Wuchereria bancrofti | 2006 |
Population genetics of concurrent selection with albendazole and ivermectin or diethylcarbamazine on the possible spread of albendazole resistance in Wuchereria bancrofti.
Topics: Albendazole; Alleles; Animals; Anthelmintics; Antiparasitic Agents; Culicidae; Diethylcarbamazine; Drug Resistance; Drug Therapy, Combination; Filariasis; Filaricides; Gene Frequency; Genetics, Population; Ivermectin; Models, Biological; Selection, Genetic; Time Factors; Wuchereria bancrofti | 2006 |
Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India.
Topics: Adolescent; Adult; Albendazole; Animals; Antiparasitic Agents; Culex; Diethylcarbamazine; Elephantiasis, Filarial; Endemic Diseases; Humans; India; Insect Vectors; Ivermectin; Mosquito Control; Polystyrenes; Program Evaluation; Public Health Practice; Water Supply; Wuchereria bancrofti | 2007 |
Probability risk transmission matrix as a decision tool for assessing methods of transmission interruption of Wuchereria bancrofti infection.
Topics: Animals; Child, Preschool; Culex; Decision Support Techniques; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Housing; Humans; Incidence; India; Infant; Infant, Newborn; Insect Vectors; Ivermectin; Male; Prevalence; Risk Factors; Wuchereria bancrofti | 2008 |
Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India.
Topics: Adult; Antiparasitic Agents; Community Health Services; Cross-Sectional Studies; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; India; Ivermectin; Male; Prevalence; Testicular Hydrocele | 2008 |
A successful outcome of gross haematuria treated with diethylcarbamazine and ivermectin.
Topics: Adult; Animals; Antiparasitic Agents; Diethylcarbamazine; Female; Filariasis; Filaricides; Hematuria; Humans; India; Ivermectin; Treatment Outcome | 2008 |
Lymphatic filariasis.
Topics: Adult; Antiparasitic Agents; Child; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Ivermectin; Loiasis; Male; Onchocerciasis, Ocular; Pregnancy | 2008 |
Impact of ivermectin drug combinations on Pediculus humanus capitis infestation in primary schoolchildren of south Indian rural villages.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Child; Diethylcarbamazine; Drug Therapy, Combination; Endemic Diseases; Filaricides; Humans; India; Ivermectin; Lice Infestations; Pediculus; Prevalence; Rural Population | 2009 |
Influence of anti-filarial chemotherapy strategies on the genetic structure of Wuchereria bancrofti populations.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Genetic Variation; Humans; Ivermectin; Random Amplified Polymorphic DNA Technique; Wuchereria bancrofti | 2011 |
Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Anthelmintics; beta-Cyclodextrins; Brugia; Chemistry, Pharmaceutical; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Excipients; Filaricides; Humans; Ivermectin; Mebendazole; Onchocerca volvulus; Onchocerciasis | 2011 |
Galactolipids from Bauhinia racemosa as a new class of antifilarial agents against human lymphatic filarial parasite, Brugia malayi.
Topics: Animals; Anthelmintics; Bauhinia; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Galactolipids; Humans; Ivermectin; Plant Extracts; Plant Leaves | 2012 |
Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
Topics: Albendazole; Animals; Community Health Services; Community Health Workers; Community Participation; Diethylcarbamazine; Disease Eradication; Drug Administration Schedule; Elephantiasis, Filarial; Endemic Diseases; Filaricides; Global Health; Health Policy; House Calls; Humans; India; Ivermectin; Medication Adherence; Microfilariae; National Health Programs; Preventive Health Services; Workforce | 2013 |
A longitudinal analysis of the effect of mass drug administration on acute inflammatory episodes and disease progression in lymphedema patients in Leogane, Haiti.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Child; Diethylcarbamazine; Elephantiasis, Filarial; Female; Haiti; Humans; Inflammation; Ivermectin; Male; Middle Aged; Young Adult | 2014 |
Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model.
Topics: Animals; Brugia malayi; Diethylcarbamazine; Female; Filariasis; Filaricides; Ivermectin; Lactic Acid; Male; Microfilariae; Murinae; Nanocapsules; Parasite Load; Parasitic Sensitivity Tests; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol | 2014 |
Liquid chromatography-mass spectrometry analysis of diethylcarbamazine in human plasma for clinical pharmacokinetic studies.
Topics: Albendazole; Chromatography, Liquid; Diethylcarbamazine; Elephantiasis, Filarial; Humans; Ivermectin; Mass Spectrometry; Plasma; Solid Phase Extraction | 2014 |
Immunomodulatory effect of diethylcarbamazine in mice infected with Nocardia brasiliensis.
Topics: Animals; Antibody Formation; Antiparasitic Agents; Cell Proliferation; Cells, Cultured; Diethylcarbamazine; Disease Models, Animal; Humans; Immunomodulation; Ivermectin; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mycetoma; Neutrophils; Nocardia; Reactive Oxygen Species | 2014 |
Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Topics: Adult; Albendazole; Animals; Anthelmintics; Auranofin; Brugia malayi; Cattle; Cell Line; Diethylcarbamazine; Drug Repositioning; Elephantiasis, Filarial; Female; Filaricides; Gerbillinae; Haplorhini; Humans; Ivermectin; Loa; Loiasis; Microfilariae; Onchocerca volvulus; Onchocerciasis | 2015 |
Antifilarial activity of diterpenoids from Taxodium distichum.
Topics: Animals; Brugia malayi; Diethylcarbamazine; Disease Models, Animal; Diterpenes; Elephantiasis, Filarial; Female; Filaricides; Gerbillinae; Humans; Ivermectin; Male; Microfilariae; Murinae; Plant Components, Aerial; Plant Extracts; Taxodium | 2016 |
Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
Topics: Albendazole; Animals; Computer Simulation; Culex; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis, Filarial; Filaricides; Humans; India; Ivermectin; Models, Biological; National Health Programs; Rural Health; Wuchereria bancrofti | 2016 |
The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.
Topics: Africa; Albendazole; Animals; Anthelmintics; Antinematodal Agents; Asia; Child; Diethylcarbamazine; Elephantiasis, Filarial; Female; Helminthiasis; Humans; Ivermectin; Male; National Health Programs; Prevalence; Schools; Soil; World Health Organization | 2016 |
Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Diethylcarbamazine; Drug Administration Schedule; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Global Health; Humans; Ivermectin; Models, Statistical | 2017 |
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Topics: Africa; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Humans; Ivermectin; Onchocerciasis | 2017 |
Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets
Topics: Albendazole; Animals; Child; Cross-Sectional Studies; Diethylcarbamazine; Disease Eradication; Elephantiasis, Filarial; Family Characteristics; Female; Filaricides; Humans; Insecticides; Ivermectin; Male; Mass Drug Administration; Prevalence; Surveys and Questionnaires; Tanzania; Wuchereria bancrofti | 2017 |
Global programme to eliminate lymphatic filariasis: progress report, 2016.
Topics: Albendazole; Anthelmintics; Diethylcarbamazine; Disease Eradication; Drug Therapy, Combination; Elephantiasis, Filarial; Endemic Diseases; Global Health; Humans; Ivermectin; Loiasis; Neglected Diseases; Onchocerciasis; Program Evaluation | 2017 |
Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Topics: Africa South of the Sahara; Albendazole; Animals; Diethylcarbamazine; Drug Synergism; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Loiasis; Male; Mass Drug Administration; Onchocerca; Onchocerciasis; Wuchereria bancrofti | 2018 |
Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models.
Topics: Albendazole; Animals; Computer Simulation; Diethylcarbamazine; Disease Eradication; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Mass Drug Administration; Microfilariae; Models, Theoretical | 2018 |
Recognition and killing of Brugia malayi microfilariae by human immune cells is dependent on the parasite sample and is not altered by ivermectin treatment.
Topics: Animals; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; High-Throughput Nucleotide Sequencing; Humans; Ivermectin; Microfilariae; Monocytes; Neutrophils | 2018 |
Novel Findings of Anti-Filarial Drug Target and Structure-Based Virtual Screening for Drug Discovery.
Topics: Albendazole; Amino Acid Sequence; Animals; Antinematodal Agents; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcium-Binding Proteins; Diethylcarbamazine; Drug Discovery; Drug Evaluation, Preclinical; Filariasis; Itraconazole; Ivermectin; Models, Molecular; Quantitative Structure-Activity Relationship | 2018 |
Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana.
Topics: Albendazole; Animals; Anopheles; Antigens, Helminth; Brugia malayi; Child; Child, Preschool; Cross-Sectional Studies; Diethylcarbamazine; Elephantiasis, Filarial; Female; Filaricides; Ghana; Humans; Ivermectin; Male; Mass Drug Administration; Microfilariae; Parasite Load; Risk Factors; Rural Population; Wuchereria bancrofti | 2019 |
Frequency and Clinical Significance of Localized Adverse Events following Mass Drug Administration for Lymphatic Filariasis in an Endemic Area in South India.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Humans; India; Ivermectin; Male; Mass Drug Administration | 2020 |
Imported loiasis in France: a retrospective analysis of 167 cases with comparison between sub-Saharan and non sub-Saharan African patients.
Topics: Adolescent; Adult; Africa, Northern; Animals; Black People; Child; Child, Preschool; Communicable Diseases, Imported; Diethylcarbamazine; Female; Humans; Infant; Infant, Newborn; Ivermectin; Loa; Loiasis; Male; Middle Aged; Paris; Prevalence; Retrospective Studies; Treatment Outcome; Tropical Medicine; Young Adult | 2020 |
Single-Dose Triple-Drug Therapy for
Topics: Albendazole; Animals; Antigens, Helminth; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Follow-Up Studies; Humans; Ivermectin; Male; Parasite Load; Wuchereria bancrofti | 2020 |
A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018.
Topics: Albendazole; Animals; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Male; Mass Drug Administration; Program Evaluation; Samoa; Wuchereria bancrofti | 2020 |
A triple-drug treatment regimen to accelerate elimination of lymphatic filariasis: From conception to delivery.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Pharmaceutical Preparations | 2020 |
Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Brugia malayi; Diethylcarbamazine; Elephantiasis, Filarial; Female; Health Education; Health Knowledge, Attitudes, Practice; Humans; Ivermectin; Kenya; Male; Mass Drug Administration; Medication Systems; Middle Aged; Patient Compliance; Treatment Refusal; Wuchereria bancrofti; Young Adult | 2020 |
Eliminating onchocerciasis within the Meme River Basin of Cameroon: A social-ecological approach to understanding everyday realities and health systems.
Topics: Adolescent; Adult; Anthelmintics; Cameroon; Data Collection; Diethylcarbamazine; Disease Eradication; Ecosystem; Environmental Exposure; Female; Health Care Costs; Humans; Interviews as Topic; Ivermectin; Male; Mass Drug Administration; Middle Aged; Onchocerciasis; Patient Acceptance of Health Care; Rivers; Socioeconomic Factors; Young Adult | 2021 |
Assessing factors influencing communities' acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana.
Topics: Albendazole; Community Health Services; Cross-Sectional Studies; Data Collection; Diethylcarbamazine; Disease Eradication; Drug Combinations; Elephantiasis, Filarial; Guyana; Humans; Ivermectin; Mass Drug Administration; Patient Acceptance of Health Care; Sentinel Surveillance; Surveys and Questionnaires | 2021 |
Lessons Learned from the Japanese Encephalitis Vaccine Introduction in India That Supported the Introduction of Ivermectin-Diethylcarbamazine-Albendazole for Lymphatic Filariasis Elimination.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Encephalitis, Japanese; Filaricides; Humans; India; Ivermectin; Japanese Encephalitis Vaccines | 2022 |
Accelerating the Uptake of WHO Recommendations for Mass Drug Administration Using Ivermectin, Diethylcarbamazine, and Albendazole.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Mass Drug Administration; World Health Organization | 2022 |
The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin | 2022 |
Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; India; Ivermectin | 2022 |
Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Mass Drug Administration | 2022 |
Lessons from Large-Scale Tolerability and Acceptability Studies of Triple Drug Mass Drug Administration Performed to Support Policy Change and Accelerate Elimination of Lymphatic Filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Mass Drug Administration; Pharmaceutical Preparations; Policy | 2022 |
Compressing the Timelines for Development and Delivery: Accelerating Access to Triple-Drug Therapy to Eliminate Lymphatic Filariasis.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Filaricides; Health Promotion; Humans; Ivermectin | 2022 |
Filariasis presenting as pancytopenia in a child.
Topics: Albendazole; Animals; Child; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Filaricides; Humans; Ivermectin; Pancytopenia; Wuchereria bancrofti | 2022 |
Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration.
Topics: Albendazole; American Samoa; Animals; Child; Diethylcarbamazine; Elephantiasis, Filarial; Filaricides; Humans; Ivermectin; Mass Drug Administration; Prevalence | 2022 |
Systemic loiasis diagnosed by direct transconjunctival observation.
Topics: Animals; Diethylcarbamazine; Humans; Ivermectin; Loa; Loiasis | 2023 |
The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipalities in Timor-Leste: a before-after assessment.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Child; Cities; Diethylcarbamazine; Female; Helminthiasis; Helminths; Humans; Impetigo; Infant; Ivermectin; Male; Mass Drug Administration; Prevalence; Scabies; Soil; Timor-Leste | 2023 |
Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study.
Topics: Albendazole; Diethylcarbamazine; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Humans; Ivermectin; Kenya; Male; Mass Drug Administration | 2023 |
Modernizing the design and analysis of prevalence surveys for neglected tropical diseases.
Topics: Albendazole; Diethylcarbamazine; Humans; Ivermectin; London; Neglected Diseases; Prevalence | 2023 |
Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.
Topics: Albendazole; Diethylcarbamazine; Elephantiasis, Filarial; Female; Humans; Ivermectin; Macrolides; Male | 2023 |
Coverage evaluation of mass drug administration with triple drug regimen in an evaluation unit in Nagpur district of Maharashtra, India.
Topics: Adolescent; Adult; Albendazole; Diethylcarbamazine; Humans; India; Ivermectin; Mass Drug Administration; Middle Aged; Young Adult | 2023 |